Shining 3D Releases 2024 Annual Report: Revenue Reaches 1.202 Billion Yuan, Profit Soars by 59%, and R\&D Investment Intensifies

On April 28, 2025, Shining 3D officially released its 2024 annual performance report, providing a comprehensive overview of the company’s achievements and development trends over the past year.

In 2024, Shining 3D achieved an operating revenue of 1.202 billion yuan, marking an 18.07% year-on-year increase from 1.018 billion yuan in 2023. Net profit was even more impressive, with net earnings attributable to shareholders reaching 226 million yuan—an increase of 59.08% year-on-year. Basic earnings per share rose to 0.58 yuan from 0.38 yuan in the previous year.

Shining 3D Technology Co., Ltd. specializes in the R\&D, production, and sales of high-precision industrial 3D scanners and digital dental equipment and software. Its core offerings include industrial 3D scanners, entry-level professional 3D scanners, intraoral dental 3D scanners, facial 3D scanners, desktop dental 3D scanners, and dental 3D printers. Recognized as a national-level “Little Giant” enterprise and a holder of advantageous intellectual property rights, the company has established a provincial-level key enterprise research institute, technical center, and postdoctoral research station in Zhejiang. During the reporting period, it garnered several prestigious honors, including the First Prize of Zhejiang Science and Technology Progress Award, China Excellent Patent Award, recognition as a “National Software Enterprise Encouraged by the State,” and the title of “Zhejiang Science and Technology Little Giant Enterprise.” In January 2024, the company was selected among the "Top 10 Signature Achievements of 2023" at the Specialized and New Manufacturing Power Annual Gala hosted by China Media Group, and in March 2024, it was included in the Ministry of Industry and Information Technology’s 8th batch of national manufacturing single-product champions.

Notably, the company’s consistent investment in research and development underscores its dedication to technological innovation. In 2024, R\&D expenses totaled 303 million yuan, accounting for 25.22% of revenue. As of December 31, 2024, Shining 3D had 1,340 employees, including 544 R\&D personnel—representing 40.60% of the workforce. Of these, 48.53% held master's or doctoral degrees.

As of the end of 2024, the company held 420 authorized patents (including 237 invention patents, with 50 granted in countries such as the US, Germany, Japan, and South Korea) and 211 software copyrights. An additional 454 invention patent applications (352 domestic, 102 international) were pending.

The company also led the drafting of several key industry standards, including the "White Light 3D Measurement System" and "Structured Light Handheld 3D Scanner," and contributed to the drafting of national metrology specifications and technical requirements for dental model scanners.

In addition, Shining 3D undertook over ten significant scientific and technological projects at the national, provincial, and municipal levels.

The company’s business structure is divided into two major segments:

1. Industrial Measurement and Professional 3D Modeling

In this domain, Shining 3D provides non-contact optical scanning and 3D visual reconstruction technologies to generate high-precision 3D data, enabling applications in design, simulation, manufacturing, and inspection. The company offers metrology-grade and professional-grade 3D scanners tailored to specific industry needs, driving the widespread adoption of high-precision 3D vision technologies.

2. Digital Dentistry

Shining 3D offers a suite of AI-powered digital dentistry solutions centered around its intraoral 3D scanners. These solutions enhance clinical efficiency and precision in procedures such as implants, restorations, and orthodontics. Its proprietary intraoral scanners—known for their exceptional cost-performance ratio—have achieved international benchmarks and are rapidly expanding into clinics and hospitals. The company also pioneered the global application of IPG photogrammetry to solve the challenge of high-precision edentulous implant placement. These innovations are rooted in its continued advancements in high-precision 3D vision technology, reshaping the interaction between patients, practitioners, and dental labs, and paving the way for new service paradigms in dentistry.

Overall Operating Performance in 2024

1. Stable Growth and Positive Momentum

   * Total assets: ¥2.092 billion, up 24.37% from the previous period.

   * Net assets attributable to shareholders: ¥1.625 billion, up 23.00%.

   * Operating revenue: ¥1.202 billion, up 18.07% year-on-year.

   * Net profit attributable to shareholders: ¥225.82 million; adjusted for share-based compensation, ¥255.72 million.

   * Net profit excluding non-recurring items: ¥171.66 million; adjusted, ¥201.55 million.

2. Relentless Focus on Innovation

   * R\&D expenditure reached ¥303.16 million (including ¥14.86 million in share-based compensation), comprising 25.22% of revenue.

   * Global patent portfolio included 420 authorized patents and 454 pending applications.

   * The company’s Hangzhou R\&D hub led continuous product enhancement and innovation across Chengdu and Tianjin branches.

   In industrial 3D modeling, Shining 3D launched integrated wireless and large-format laser scanning solutions for high-end manufacturing, strengthening its leadership in precision and efficiency. Several new wireless all-in-one 3D scanners were also introduced, featuring cutting-edge designs and multifunctionality.

   In digital dentistry, the company refined its intraoral scanning products and software intelligence while deepening integration with clinical applications. The self-developed IPG photogrammetry system enabled precise edentulous implant placement, bolstered by versatile and intelligent proprietary software. These efforts contributed to the establishment of a complete, intelligent digital dentistry workflow.

   The company also completed its new R\&D and industrialization base for high-precision 3D vision at the end of 2024, expanding its capacity in R\&D, testing, and manufacturing.

3. Accelerated Globalization and Market Diversification

   * Overseas revenue reached ¥792 million, a 28.65% year-on-year increase, accounting for 65.88% of total revenue.

   * Expanded local offices and subsidiaries in Germany (Stuttgart), the U.S. (California and Florida), and Japan (Tokyo), forming a comprehensive international sales and service network.

   * Participated in global exhibitions and hosted international partner and user conferences to address regional market needs with localized, high-quality offerings.

   * Continued to scale overseas teams and enhanced local talent capabilities through rotational assignments from headquarters.

4. Talent Development and Team Building

   * Master’s and doctoral-level employees increased from 281 to 389, now comprising 30% of total staff.

   * Comprehensive employee training was implemented across general, technical, and managerial domains to boost competency and innovation.

   * Collaborations with leading institutions—including Zhejiang University, Peking University School of Stomatology, and West China Hospital of Stomatology, Sichuan University—fostered a steady pipeline of R\&D talent.

5. Launch of High-Precision 3D Vision Technology Base

   * Completed in late 2024, the new base includes over ten dedicated labs, including a “long-distance metrology lab,” to support enhanced testing, precision validation, and rapid product industrialization.

   * On-site production facilities and modern intelligent warehousing systems further improved quality control and delivery capabilities.

   * The base significantly strengthens the company’s comprehensive capabilities in R\&D, manufacturing, and technological advancement.